Market Place
Sourcing Support
Chiesi, Affibody sign $637M respiratory disease collab
08 Mar 2023 //
FIERCE BIOTECH
ACELYRIN, Affibody. Inmagene Biopharma Announce Data from PII Trial of Izokibep
03 Jun 2022 //
PRNEWSWIRE
ACELYRIN, Affibody & Inmagene Shows +ve Interim Results from Phase 2 of Izokibep
13 Dec 2021 //
PRNEWSWIRE
Acelyrin snags $250M, licenses Affibody IL-17 asset for 3 trials
16 Nov 2021 //
FIERCEBIOTECH
Affibody and Inmagene announce First Patient Dosed in Phase 2 ASPIRE Trial
25 Aug 2021 //
PRESS RELEASE
Affibody Announces Initiation of Confirmatory Phase 2 Trial of ABY-035
10 Nov 2020 //
MYNEWSDESK
Affibody Announces +VE Top-Line Data from Ph 2 Proof-of-Concept Trial of ABY-035
16 Jun 2020 //
AFFIBODY
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.